|
Location: Unknown Location wrong? Click here What's This? |
Substituted 3-phenanthridiNone derivatives as 5-alpha-reductase inhibitors useful in the prevention and treatment of hyperandrogenic disorders | |||||
| Inventors: | nn; William K.(Westfield, NJ). |
| Assignee: | Merck & Co., Inc. (Rahway, NJ). |
| Appl. No.: | 522,350 |
| Filed: | Sept. 15, 1995 |
| PCT Filed: | Mar. 22, 1994 |
| PCT No: | PCT/US94/03080 |
| 371 Date: | Sept. 15, 1995 |
| 102(e) Date: | Sept. 15, 1995 |
| PCT Pub. No.: | WO94/21614 |
| PCT Pub. Date: | Sept. 29, 1994 |
Related U.S. Application Data
| Continuation of (including streamline cont.) Ser. No. 36,645, Mar. 24, 1993, abandoned. |
| Intl. Cl. : | C07D 221/12, C07D 401/12 |
| Current U.S. Cl.: | 546/108; 514/298; 546/109 |
| Field of Search: | 546/108, 109; 514/298 |
References Cited | [Referenced By:]
U.S. Patent Documents
| 2,227,876 | Jan., 1941 | Bolt | 546/77 |
| 3,239,417 | Mar., 1966 | Ditullio et al. | 514/284 |
| 3,264,301 | Aug., 1966 | Doorenboos et al. | 546/77 |
| 3,285,918 | Nov., 1966 | Doorenboos et al. | 544/245 |
| 3,567,733 | Mar., 1971 | Nomine et al. | 546/79 |
| 4,220,775 | Sept., 1980 | Rasmusson et al. | 546/77 |
| 4,317,817 | Mar., 1982 | Blohm et al. | 514/150 |
| 4,377,584 | Mar., 1983 | Rasmusson et al. | 514/284 |
| 4,596,812 | Jun., 1986 | Chidsey, III et al. | 514/256 |
| 4,732,897 | Mar., 1988 | Cainelli et al. | 514/228.2 |
| 4,760,071 | Jul., 1988 | Rasmusson et al. | 514/284 |
| 4,845,104 | Jul., 1989 | Carlin et al. | 514/284 |
| 4,859,681 | Aug., 1989 | Rasmusson et al. | 514/284 |
| 4,882,319 | Nov., 1989 | Holt et al. | 514/119 |
| 4,910,226 | Mar., 1990 | Holt et al. | 514/573 |
| 5,247,091 | Sept., 1993 | Mueller-Lehar | 546/105 |
Foreign Patent Documents
| 970692 | Jul., 1975 | CA | |
| 0004949 | Oct., 1979 | EP | |
| 0155096 | Sept., 1985 | EP | |
| 0200859 | Nov., 1986 | EP | |
| 0277002 | Jun., 1988 | EP | |
| 0289327 | Nov., 1988 | EP | |
| 0314199 | May, 1989 | EP | |
| 0343954 | Nov., 1989 | EP | |
| 0375344 | Jun., 1990 | EP | |
| 0375345 | Jun., 1990 | EP | |
| 0375347 | Jun., 1990 | EP | |
| 0375349 | Jun., 1990 | EP | |
| 1465544 | Nov., 1965 | FR | |
| WO91/12261 | Aug., 1991 | WO |
Vila et al., Tet. Letters (1989), vol. 45, pp. 4951-4960, "Conformational Analysis of the 4a-Methyl Octahydrophenanthrene System".
Iida et al., Heterocycles (1983), vol. 20, pp.227-230, "A New Synthesis of Phenanthridine Derivatives".
Schultz et al., J. Am. Chem. Soc. (1978), vol. 100, pp. 2140-2149, "Heteroatom Directed Photoarylation. Synthetic Potential of the Heteroatom Sulfur".
Neri et al., Endo. (1972), vol. 91, No. 2, pp. 427-437, "A Biological Profile of a Non-steroidal Antiandrogen, SCH 13521 . . . ".
Nayfeh et al., Steroids, vol. 14 (1969), pp. 269-283, "Metabolism of Progesterone by Rat Testicular Homogenates-III".
Voight et al., Endo., vol. 92 (1973), p.1216, "The Antiandrogenic Action of 4-Androsten-3-one-17beta-Carboxylic Acid and its Methyl Ester on Hamster Flank Organ".
Doorenbos et al., J. Pharm. Sci., vol. 62, No. 4 (1973), pp. 638-640, "Synthesis & Antimicrobial Properties of 17Beta-Isopentyloxy-4-Aza-5 Alpha-Androstane and the 4-Methyl Derivative".
Doorenbos et al., J. Pharm. Sci., vol. 60, No. 8 (1971), pp. 1234-1235, "4,17 Alpha-Dimethyl-4-Aza-5 Alpha-Androstan-17 beta-ol Acetate & Related Azasteroids".
Doorenbos et al., J. Pharm. Sci., vol. 63, No. 4 (1974), pp. 620-622, "Synthesis & Evaluation of Antimicrobial Properties of Amidinoazaandrostanes and Guanidinoazaandrostanes".
Rasmusson et al., J. Med. Chem., vol. 29, No.11 (1986), pp. 2298-3115, "Aza Steroids: Structure-Activity Relationships . . . ".
Brooks et al., Prostate, vol. 9, No. 1 (1986), pp. 65-75, "Prostatic Effects Induced in Dogs by . . . 5 alpha-Reductase Inhibitors".
Brooks et al., Steroids, vol. 47, No. 1 (1986), pp. 1-19, "5 Alpha-Reductase Inhibitory . . . Activities of Some 4-Aza-Steroids in the Rat".
Liang et al., Endo., vol. 117, No. 2, (1986), pp. 571-579, "Species Differences in Prostatic Steroidal 5 Alpha-Reductases of Rat, Dog and Human".
Rasmusson et al., J. Med. Chem., vol. 27, No. 12 (1984), pp. 1690-1701, "Azasteroids as Inhibitors of Rat Prostatic 5 Alpha-Reductase".
Back et al., J. Org. Chem, vol. 46, No. 7 (1981), pp. 1442-1446, "N-Chloroazasteroids . . . ".
Liang et al., Chem. Abstracts, vol. 95, 109055j, "Inhibition of 5-Alpha-Receptor Binding . . . by a 4-Methyl-4-Aza-Steroid" (1985).
Kadohama et al., JNCL, vol. 74, No. 2 (Feb. 1985), pp. 475-481, "Retardation of Prostate Tumor Progression in the Noble Rat by 4-Methyl-4-Aza-Steroidal Inhibitors of 5 Alpha-Reductase".
Andriole et al., The Prostate, vol. 10 (1987), pp. 189-197, "The Effect of 4MA . . . on the Growth of . . . Human Tumors . . . ".
Bingham et al., J. Endocr., vol. 57 (1973), pp. 111-121, "The Metabolism of Testosterone by Human Male Scalp Skin".
Kedderis et al., Toxicol. Appl. Pharmacol., vol. 103 (1990), pp. 222-227, "Studies with Nitrogen-Containing Steroids . . . ".
Metcalf et al., Bioinorganic Chemistry, vol. 17 (1986), pp. 372-376, "Patent Inhibition of Human Steroid . . . by 3-Androstene-3-Carboxylic Acid".
Levy et al., Biochemistry, vol. 29 (1990), pp. 2815-2824, "Inhibition of Rat Liver Steroid 5 Alpha-Reductase . . . ".
Holt et al., J. Med. Chem., vol. 33 (1990), pp. 943-950, "Steroidal A Ring Carboxylic Acids . . . ".
Levy et al., J. Steroid Biochem., vol. 34, No. 1-6 (1989), pp. 571-575, "Interaction Between Rat Prostatic 5 Alpha-Reductase . . . ".
Holt et al., J. Med. Chem., vol. 33 (1990), pp. 937-942, "Steroidal A Ring Aryl Carboxylic Acids . . . ".
Metcalf et al., TIPS (Dec. 1989), vol. 10, pp. 491-495, "Inhibitors of . . . 5 Alpha-Reductase in Benign Prostatic Hyperplasia . . . ".
Murphy et al., Steroids, vol. 35, No. 3 (Mar. 1980), pp. 1-7, "Effect of Estradiol on a . . . Binding Protein in the Uterus of the Mouse".
Stone et al., Prostate, vol. 9 (1986), pp. 311-318, "Estrogen Formation in Human Prostatic Tissue . . . ".
Brooks et al., Steroids, vol. 47, No. 1 (1986), pp. 1-19, "5 Alpha-Reductase Inhibitory . . . Activities of Some 4-Azasteroids . . . ".
Labrie et al., Lancet, No. 8515 (1986), pp. 1095-1096, "Combination Therapy in Prostate Cancer".
Rittmaster et al., J. Clin. Endocrin & Metab., vol. 55, No. 1 (1987), pp. 188-193, "The Effects of . . . a 5 Alpha-Reductase Inhibitor . . . ".
Diani et al., J. Clin. Endoc. & Metab., vol. 74, No. 2 (1990), pp. 345-350, "Hair Growth Effects of Oral Administration of Finasteride . . . ".
Bruchovsky et al., J. Clin. Endoc. Metab., vol. 67, No. 4 (1988), pp. 808-816, "Kinetic Parameters of 5 Alpha-Reductase Activity in Stroma & Epithelium of Normal, Hyperplastic & Carcinomatous Human Prostates".
Hudson, J. Steroid Biochem., vol. 26, No. 3 (1987), pp. 349-353, "Comparison of Nuclear 5 Alpha-Reductase Activities in the Stromal and Epithelial Fractions of Human Prostatic Tissue".
Moore et al., J. Biol. Chem., vol. 251, No. 19 (1976), pp. 5895-5900, "Steroid 5 Alpha-Reductase in Cultured Human Fibroblasts".
Andersson et al., J. Biol. Chem., vol. 264, No. 27 (1989), pp. 16249-16255, "Expession Cloning & Regulation of Steroid 5 Alpha-Reductase, an Enzyme Essential for Male Sexual Differentiation".
Andersson et al., Proc. Nat'l Acad. Science, vol. 87 (1990), pp. 3640-3644, "Structural & Biochemical Properties of Cloned and Expressed Human and Rat Steroid 5 Alpha-Reductases".
Andersson et al., Nature, vol. 354 (Nov. 14, 1991), pp. 159-161, "Deletion of Steroid 5 Alpha-Reductase-2 Gene in Male Pseudohermaphroditism".
Wilson, Biol. of Reproduction, vol. 46 (1992), pp. 168-173, "Syndromes of Androgen Resistance".
Geldolf et al., Eur. J. Cancer, vol. 26, No. 2 (1990), pp. 188, "Enzyme Inhibitors in Hormone Dependent Prostate Cancer Growth".
Geldolf et al., J. Cancer Res. Clin. Oncol., vol. 118 (1992), pp. 50-55, "Consideration of the Use of . . . 4MA . . . in Prostate Cancer Research".
Brooks et al., The Prostate, vol. 18 (1991), pp. 215-227, "Effect of Castration, DES, Flutamide, and MK-906 on Growth of the Dunning Rat Prostatic Carcinoma".
Jones et al., J. Med. Chem., vol. 36 (1993), pp. 421-423, "Nonsteroidal Inhibitors of Human Type 1 Steroid 5alpha-Reductase".
Masubuchi et al., Eur. J. Pharm., vol. 183, No. 5 (1990), p. 1757, "Lack of DHT Inhibition . . . by Treatment of 4MA . . . ".
Primary Examiner: Rotman; Alan L.
Assistant Examiner: Rotman; A.
Attorney, Agent or Firm: Fitch; Catherine D., Winokur; Melvin
Abstract
The present invention provides for the preparation of compounds,namely, 3-phenanthridiNones and their derivatives and their unique ability to inhibit 5-alpha-reductase or their isozymes thereof in mammals enabling said compounds for treating hyperandrogenic conditions of acne, androgenic alopecia, male pattern baldness,female hirsutism,benign prostatic hyperplasia, prostatitis and prostatic cancer.
1 Claim, No Drawings
|
Location: Unknown Location wrong? Click here What's This? |
More Info: Home | About Regrowth.com | How
to Advertise | Privacy Policy | Advertising
Policy | Contact Us
Site Map | Copyright © 2007
The Regrowth Network. All rights reserved. Legal Disclaimer
Other Cool Sites: Hair Loss Treatments - Body for Life Tracker - MedSpert
Propecia ® is
a registered trademark of Merck.
Avodart ® is a
registered trademark of GlaxoSmithKline.
Rogaine ® is a
registered trademark of Pfizer. Nizoral ® is
a registered trademark of McNeil Consumer & Specialty Pharmaceuticals.